Back to results
US 8,133,886 B2Granted
Heterobicyclic carboxamides as inhibitors for kinases
AssigneeNovartis AG
InventorsGuido Bold, Andrea Vaupel, Carole Pissot Soldermann, Paul W Manley
Life of this patent
Estimating the term…
Abstract
The invention relates to novel compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula (I) and to the use of a compound of formula (I) for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumor diseases.
Claims12
A compound of the formula IA
- wherein R1 is hydroxyl, lower-alkoxy-lower alkyl, lower alkylsulfonylamino, amino-lower alkylamino, N-mono- or N,N-di-(lower alkyl)amino-lower alkylamino, N-mono- or N,N-di-(lower alkyl)amino-carbonyl-amino-, piperazinyl-lower alkylamino, N-lower alkylpiperazinyl-lower alkylamino, hydrazine, mono- di- or tri-(lower alkyl)-substituted hydrazine,
- R2 is phenyl substituted by a substituent selected from the group consisting of phenoxy, piperazinyl-lower alkyl, lower-alkylpiperazinyl-lower alkyl, C3-C8-cycloalkyl-piperazinyl-lower alkyl, piperidinyl-lower alkyl, lower-alkylpiperidinyl-lower alkyl, piperidinyliden-lower alkyl, lower-alkylpiperidinyliden-lower alkyl, piperidinyloxy, lower alkylpiperidinyloxy, pyrrolidinyl, amino-pyrrolidinyl, N-mono- or N,N-di-lower alkylaminopyrrolidinyl and 9-lower alkyl-3,9-diazabicyclo[3.3.1]non-3-yl-lower alkyl, or in all cases by one of the mentioned substituents and in addition by a moiety selected from lower alkyl, C3-C8-cycloalkyl, halo, halo-lower alkyl, halo-lower alkoxy and lower alkoxy;
- or is 2H-pyrazolyl that is unsubstituted or substituted by lower alkyl and by one or two moieties independently selected from lower alkoxyphenyl and lower alkoxyphenylphenyl;
- or is phenyl substituted by one or two moieties independently selected from lower alkyl, C3-C8-cycloalkyl, halo, halo-lower alkyl, halo-lower alkoxy, or by lower alkoxy, or is 2H-pyrazolyl substituted by halophenyl and lower alkyl;
- or wherein R1 is halo, amino, lower alkylamino, lower alkanoylamino, lower alkoxycarbonylamino, C3-8cycloalkylcarbonyl amino or hydroxyl-lower alkyl and
- R2 is phenyl substituted by a substituent selected from the group consisting of phenoxy, piperazinyl-lower alkyl, lower-alkylpiperazinyl, lower-alkylpiperazinyl-lower alkyl, C3-C8-cycloalkyl-piperazinyl-lower alkyl, phenyl lower-alkyl piperaziyl, piperidinyl-lower alkyl, lower-alkylpiperidinyl-lower alkyl, amino piperidinyl, lower alkoxycarbonylamino piperidinyl, piperidinyliden-lower alkyl, lower-alkylpiperidinyliden-lower alkyl, piperidinyloxy, lower alkylpiperidinyloxy, pyrrolidinyl, amino-pyrrolidinyl, N-mono- or N,N-di-lower alkylaminopyrrolidinyl, N-mono- or N,N-di-lower alkylaminopyrrolidinyl lower alkyl, 1,1-dioxido-4-thiomorpholinyl, and 9-lower alkyl-3,9-diazabicyclo[3.3.1]non-3-yl-lower alkyl, or in all cases by one of the mentioned substituents and in addition by a moiety selected from lower alkyl, C3-C8-cycloalkyl, halo, halo-lower alkyl, halo-lower alkoxy and lower alkoxy;
- or is 2H-pyrazolyl that is unsubstituted or substituted by lower alkyl and by one or two moieties independently selected from lower alkoxyphenyl and lower alkoxyphenylphenyl;
- A, B and X are independently selected from C(R3) or N, with the proviso that X is C(R3), one of A and B is N and the other is C(R3);
- R3 is lower alkyl, halo or hydrogen;
- Y is O, S, S(O), S(O)2, CH2 or CH2—CH2;
- and
- W is absent or is lower alkylene;
- a tautomer and/or a salt thereof.
10 more elements
Dependencies are inferred from the claim text.